Results 61 to 70 of about 52,877 (267)

Ivermectin as a potential drug for treatment of COVID-19: an in-sync review with clinical and computational attributes

open access: yesPharmacological Reports, 2021
COVID-19 cases are on surge; however, there is no efficient treatment or vaccine that can be used for its management. Numerous clinical trials are being reviewed for use of different drugs, biologics, and vaccines in COVID-19.
H. Kaur   +5 more
semanticscholar   +1 more source

Molecular mechanisms of Cys-loop ion channel receptor modulation by ivermectin

open access: yesFrontiers in Molecular Neuroscience, 2012
Ivermectin is a gold standard anthelmintic drug that works by potently depressing neuronal activity and muscular contractility in arthropods and nematodes. At the molecular level, ivermectin activates inhibitory glutamate-gated chloride channels (GluClRs)
Timothy eLynagh, Joe eLynch
doaj   +1 more source

Ivermectin: An Anthelmintic, an Insecticide, and Much More

open access: yesTrends in Parasitology, 2020
Here we tell the story of ivermectin, describing its anthelmintic and insecticidal actions and recent studies that have sought to reposition ivermectin for the treatment of other infectious diseases.
Richard J. Martin   +2 more
semanticscholar   +1 more source

The mechanisms of action of ivermectin against SARS-CoV-2—an extensive review

open access: yesJournal of antibiotics (Tokyo. 1968), 2021
Considering the urgency of the ongoing COVID-19 pandemic, detection of new mutant strains and potential re-emergence of novel coronaviruses, repurposing of drugs such as ivermectin could be worthy of attention.
A. Zaidi, P. Dehgani-Mobaraki
semanticscholar   +1 more source

Clinical study evaluating the efficacy of ivermectin in COVID‐19 treatment: A randomized controlled study

open access: yesJournal of Medical Virology, 2021
Researchers around the world are working at record speed to find the best ways to treat and prevent coronavirus disease 2019 (COVID‐19). This study aimed to evaluate the efficacy of ivermectin for the treatment of hospitalized mild to moderate COVID‐19 ...
S. Abdel-salam   +15 more
semanticscholar   +1 more source

Ivermectin Treatment and Sanitation Effectively Reduce Strongyloides stercoralis Infection Risk in Rural Communities in Cambodia [PDF]

open access: yes, 2016
BACKGROUND: Strongyloides stercoralis is the only soil-transmitted helminth with the ability to replicate within its host, leading to long-lasting and potentially fatal infections. It is ubiquitous and its worldwide prevalence has recently been estimated
Virak Khieu (236174)   +31 more
core   +1 more source

Exploring the binding efficacy of ivermectin against the key proteins of SARS-CoV-2 pathogenesis: an in silico approach

open access: yesFuture Virology, 2021
Aim: COVID-19 is currently the biggest threat to mankind. Recently, ivermectin (a US FDA-approved antiparasitic drug) has been explored as an anti-SARS-CoV-2 agent.
Abhigyan Choudhury   +6 more
semanticscholar   +1 more source

Selamectin is the avermectin with the best potential for Buruli ulcer treatment [PDF]

open access: yes, 2015
A comprehensive analysis was done to evaluate the potential use of anti-parasitic macrocyclic lactones (including avermectins and milbemycins) for Buruli ulcer (BU) therapy.
Gerd Pluschke   +15 more
core   +2 more sources

Ivermectin and Novel Coronavirus Disease (COVID-19): Keeping Rigor in Times of Urgency

open access: yesAmerican Journal of Tropical Medicine and Hygiene, 2020
Ivermectin and Novel Coronavirus Disease (COVID-19): Keeping Rigor in Times of ...
Carlos J. Chaccour   +3 more
semanticscholar   +1 more source

Ivermectin susceptibility and sporontocidal effect in Greater Mekong Subregion Anopheles

open access: yesMalaria Journal, 2017
Background Novel vector control methods that can directly target outdoor malaria transmission are urgently needed in the Greater Mekong Subregion (GMS) to accelerate malaria elimination and artemisinin resistance containment efforts. Ivermectin mass drug
Kevin C. Kobylinski   +10 more
doaj   +1 more source

Home - About - Disclaimer - Privacy